Previous Article | Next Article 
J Virol, January 1998, p. 633-640, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Stimulation of Cyclin-Dependent Kinase Activity and
G1- to S-Phase Transition in Human Lymphocytes by the Human
T-Cell Leukemia/Lymphotropic Virus Type 1 Tax Protein
Iris
Schmitt,1
Oliver
Rosin,1
Peter
Rohwer,2
Manfred
Gossen,3 and
Ralph
Grassmann1,*
Institut für Klinische und Molekulare
Virologie der Friedrich-Alexander Universität
Erlangen-Nürnberg1 and
Institut für Klinische Immunologie der
Friedrich-Alexander Universität
Erlangen-Nürnberg,2 91054 Erlangen,
and
Zentrum für Molekularbiologie, 69120 Heidelberg,3 Germany
Received 12 May 1997/Accepted 14 October 1997
 |
ABSTRACT |
The human T-cell leukemia/lymphotropic virus type 1 (HTLV-1)
induces a malignant lymphocytic disease. The HTLV-1 transactivator protein, Tax, is believed to be crucial for the development of the
disease since it is transforming in vitro and induces tumors in
transgenic animals. Although the transcriptional modulation of viral
and cellular gene expression by Tax has been analyzed thoroughly, it
has remained unclear how the Tax functions act on the cell cycle of
primary T cells. To investigate the mechanism of Tax-mediated T-cell
stimulation, we transduced primary human cord blood T cells with a
conditional, tetracycline repressor-based tax expression
system. Permanent Tax expression results in an abnormal proliferation
of T cells which closely resemble HTLV-1-infected lymphocytes.
Suppression of Tax synthesis stopped lymphocyte growth and caused cell
cycle arrest in the G1 phase. Upon reinduction of
tax expression, the arrested cells entered the S phase.
This showed that Tax has mitogenic activity, which is required for stimulating the G1- to S-phase transition of immortalized
lymphocytes. In mammalian cells, the G1-phase progression
is controlled by the serial activation of several cyclin-dependent
kinases (Cdks), starting with Cdk4 and Cdk6. In the presence of Tax,
both Cdk4 and Cdk6 were activated. The suppression of Tax synthesis,
however, resulted in a significant reduction of the Cdk4 and Cdk6
activities but did not influence the expression of Cdk4, Cdk6, or
cognate D-type cyclin proteins. These data suggest that Tax induces
Cdk4 and Cdk6 activity in primary human T lymphocytes; this Cdk
activation is likely to account for the mitogenic Tax effect and for
the abnormal T-cell proliferation of HTLV-1-infected lymphocytes.
 |
INTRODUCTION |
The human T-cell
leukemia/lymphotropic virus type 1 (HTLV-1) induces adult
T-cell leukemia (50, 66), a unique clinical disorder of
mature CD4+ lymphocytes. The leukemogenic properties of the
virus are accompanied by its capacity to change the growth properties
of T cells from patients, asymptomatic carriers, and in vitro-infected
peripheral blood cell cultures. In contrast to normal T cells, these
cells proliferate permanently without antigen stimulation (reviewed in
reference 25). The HTLV-induced growth
transformation results primarily in interleukin-2 (IL-2)-dependent cell
lines, which closely resemble activated and functional T lymphocytes.
After prolonged in vitro culture, sequential changes in the expression of proliferation-related functions are observed. These include the
eventual conversion to IL-2-independent growth caused by a constitutive
stimulation of the IL-2 receptor-associated Jak-STAT pathway (11,
44). This additional change is found associated with the loss of
T-cell receptor and T-cell functions and a lack of Lck tyrosine kinase
expression (29, 38). Observations made with
HTLV-1-transformed cells indicate an abnormal regulation of the cell
cycle. These cells contained inactive hyperphosphorylated retinoblastoma (Rb) protein and were resistant to cell cycle arrest induced by transforming growth factor
(28).
Additionally, the tumor suppressor p53, although unmutated, showed
increased stability (53).
The HTLV-1 genome encodes a regulatory protein,
p40tax, that resembles a viral oncogene and thus
is believed to be responsible for the transforming features of the
virus. Tax induces multiple mesenchymal tumors and leukemia in
transgenic mice (26, 47), and it can alter the growth
properties of rodent fibroblast cell lines (51, 62) and
human T cells (4, 6). In the context of a
transformation-defective rhadinovirus vector, Tax can immortalize primary human lymphocytes. Cells immortalized by
tax-expressing rhadinoviruses closely resemble HTLV-infected
lymphocytes in phenotype and growth behavior (22, 23).
Biochemically, p40tax functions as a
transcriptional transactivator protein; it stimulates viral
transcription and modulates an array of cellular genes by acting on
transcription factors CREB (1, 2, 10), NF-
B (33, 58,
59), and p67SRF (17, 18). It
enhances the transcription of proto-oncogenes like c-fos and
c-jun (17, 18), the genes for the
chain of the IL-2 receptor (IL-2R
) (12, 30), and several cytokines (27, 37, 46). However, it suppresses the synthesis of the human DNA polymerase
, an enzyme important for DNA repair
(31). Recently, Tax was shown to bind to
p16INK-4A (61), an inhibitor of
cyclin-dependent kinases Cdk4 and Cdk6. These Cdks are essential for
the control of the G1-phase progression (8, 52, 54,
56, 63), and they are the first to be activated after cells are
stimulated from a quiescent state (40, 41, 43). The kinases
are assembled with D-type cyclins in holoenzyme complexes that
phosphorylate Rb proteins (14, 34, 43). Interestingly, the
negative control of the Cdk4-Cdk6 signalling pathway is frequently impaired or bypassed in transformed and tumor cells (35,
48), implicating that a malfunction in these kinases could result
in deregulation of cellular growth.
The mechanism by which Tax influences the growth of transformed primary
human T cells is not well understood; it is not even known whether the
growth of these cells depends on the presence of Tax. One attractive
speculation is that Tax activates Cdks by pulling off INK-4 inhibitors
like p16INK-4A and thus acts as a growth factor
for the HTLV-infected lymphocytes. To address the growth dysregulation
of immortalized primary T cells, which are not accessible by standard
DNA transfer techniques, we constructed rhadinovirus recombinants
containing a tetracycline-repressible tax gene and
immortalized primary human lymphocytes. The proliferation of the
immortalized cells was reversibly arrested in the G1 phase of the cell cycle by suppression of tax transcription, thus
demonstrating that Tax stimulates the G1- to S-phase
transition in immortalized T lymphocytes. We also could show that the
activation of cyclin-dependent kinases Cdk4 and Cdk6 was dependent on
the presence of Tax. This Cdk activation provides a direct linkage of
Tax to the control of the G1 phase of T cells and may
account for the mitogenic and immortalizing Tax effect.
 |
MATERIALS AND METHODS |
Construction of recombinant rhadinovirus.
The tax
sequences were obtained as a BamHI/XhoI fragment
from pHIXSLdsph (22) and fused with the
tetracycline-regulatable promoter present in pUHG10-3 (21).
A SalI/XhoI fragment containing the
promoter-tax fusion was subsequently inserted into the
SalI site of the recombination vector pRÜneo15-N
(22), resulting in pRÜtosG. The sequences for the
modified tetracycline repressor (tTA) were derived from the plasmid
pUHD15-1 (21) as a XhoI fragment and inserted
into the SalI site of pRÜtosG, resulting in the
plasmid ptTAX. This recombination plasmid contains the modified
tetracycline repressor, the tax gene, a NeoR
selection marker, and flanking rhadinoviral sequences. These sequences
allowed homologous recombination with the genome of the rhadinovirus
herpesvirus saimiri strain 11S4 and directed the tax
expression cassettes into the right junction of unique and repetitive
sequences.
The generation and purification of the recombinant rhadinovirus
herpesvirus saimiri were performed as described previously (7,
24). Briefly, the linearized plasmid ptTAX (2 to 4 µg) and
genomic DNA of herpesvirus saimiri strain 11S4 (0.2 to 0.4 µg) were
cotransfected into OMK-637 cells, where homologous recombination took
place. This cell line is lytically infectable with herpesvirus saimiri.
Recombinant viruses were selected by use of the antibiotic G418 and
purified by five subsequent plaque isolations. The purity and correct
structure of the recombinants were verified by Southern blot analyses
as described previously (22). The hybridization probes used
were tax cDNA, herpesvirus saimiri sequences derived from
the KpnI-D fragment, and the
XhoI/BamHI fragment of pUHD15-1. The viral stocks
(Hs86-S) obtained were found to contain more than 95% recombinant
genomes.
Cell culture and immortalization of primary human T cells.
The T cell line Jurkat (HTLV-1 negative) and the HTLV-1-infected cell
line HuT102 were cultured in RPMI 1640 containing 10 to 20% fetal calf
serum (FCS), glutamine, and the antibiotics streptomycin and
penicillin. The same medium supplemented with IL-2 (20 to 40 U) was
used for the propagation of Tesi, NATI-2, and TRI-1 cells
(22). The immortalized T cell lines TRI-1 and NATI-2 are
derived from cord blood by use of a permanently transcribed tax gene. The viral vector used for the transduction of the
constitutive tax gene was the same as the vector used for
the insertion of the repressible tax gene. According to
growth characteristics and phenotype (CD25 CD45 CD2), TRI-1 and NATI-2
cells closely resemble Tesi cells, which contain recombinant virus
Hs86-S. The human CD4+ T cell line SS8BPT (65)
and its derivative SS8tetTax were maintained in a mixture (1:1) of RPMI
1640/CG (Vitromex, Vilshofen, Germany) and 20% FCS plus 50 U of IL-2
per ml. Human peripheral blood mononuclear cells were prepared from
heparin-treated cord blood by Ficoll-Hypaque (Sigma) density gradient
centrifugation, stimulated for 48 h with 5 µg of
phytohemagglutinin per ml, and infected with recombinant virus Hs86-S
as described previously. Infected peripheral blood mononuclear cells
were propagated in RPMI 1640 supplemented with 20% FCS, glutamine,
antibiotics, and 20 to 40 U of IL-2 (Boehringer, Mannheim, Germany) per
ml.
Characterization of cell lines.
For the detection of
high-molecular-weight superhelical DNA in transformed lymphocytes
(24), cells were carefully lysed on top of vertical slab
gels; cellular DNA was separated electrophoretically into chromosomal,
episomal, and linear or degraded fractions. To visualize the
recombinant viral sequences, the gels were blotted and hybridized to
X-region DNA. Surface markers were detected by monoclonal antibodies
binding to human CD4 (Leu-3a), CD8 (Leu-2a), CD45 (anti-HLe-1), CD45
RA, CD45 RO, CD3 (Leu-4), CD25 (anti-Tac), CD28, and CD69 (Leu-23).
Tetracycline (1 µg/ml)-treated (7 to 14 days) and untreated cells
were stained, washed, and fixed in 1% formaldehyde. The cells were
analyzed by flow cytometry with a FACStract analyzer with Lysis II
software (Becton Dickinson). To determine the proportions of cells in
the G1/G0 (abbreviated G1), S, and
G2/M (abbreviated G2) phases in lymphocyte
cultures, the DNA content of individual cells was analyzed. Cells
(0.8 × 106) were washed, fixed in cold 70% ethanol,
and stained with propidium iodide (50 µg of propidium iodide per ml
and 100 µg of DNase-free RNase A per ml in phosphate-buffered
saline). Flow cytometric analysis was performed with a Coulter Epics
Elite analyzer with Multicycle software (Phoenix). The DNA synthesis
rate was determined as a measure of cell proliferation. Cells were
seeded in triplicate in round-bottom microculture plates at a density
of 40,000 to 50,000 cells/100 µl and labelled with 2 µCi of
[3H]thymidine ml
1 for 12 to 16 h. Each
experiment was repeated a minimum of three times. The cells were
harvested, and the radioactivity incorporated in the DNA was
quantitated by phosphorimaging (BAS2000; FujiX).
Analysis of gene expression.
For the demonstration of
tetracycline-mediated tax suppression, OMK-637 cells were
infected with virus stocks diluted 1:10 with minimal essential medium.
The permanently growing human T cell line SS8BPT was infected with the
recombinant virus (Hs86-S) like the cord blood cells were, but without
previous stimulation, and selected by the addition of antibiotic G418.
The resulting cell line was designated SS8tetTax. To repress
tax expression, the cells were treated with tetracycline
(0.01 to 1 µg/ml). tax RNA was identified by Northern
blotting as previously described (22). Tax protein and cell
cycle control proteins were detected by Western blot analysis.
Tetracycline-treated and untreated cells were resuspended in a lysis
buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1% Nonidet P-40, 1 mM
sodium vanadate, 10 µg of aprotinin per ml, 10 µg of leupeptin per
ml, 5 mM NaF) and incubated for 15 min on ice. Lysates were cleared by
centrifugation, and equal amounts of crude cell lysates (30 µg) were
separated by gels and transferred to nitrocellulose (Amersham) or
Immobilon P (Millipore) membranes. The antibodies used to detect Tax
were prepared from hybridoma 168B17-46-34/50 (provided by B. Langton
through the AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID) or anti-Tax rabbit serum. For the detection of
cyclin-dependent kinases, cyclins, and retinoblastoma protein,
polyclonal rabbit antibodies were purchased from Santa Cruz
Biotechnology (anti-Cdk4, anti-Cdk6, anti-Rb), Dianova (anti-cyclin
D3), or Pharmingen (anti-p16INK-4A). Bound
antibodies were visualized by the enhanced chemiluminescence detection
system (Amersham). To demonstrate the repression of Tax function, cells
(5 × 106) were electroporated (900-µF charge, 250-V
potential) with 10 µg of the Tax-inducible reporter plasmid pU3RI-CAT
(23). The cells were harvested 48 h later, and the
chloramphenicol acetyltransferase (CAT) reaction was determined as
described previously (22).
Determination of cyclin-dependent kinase activity.
Cells
were lysed in buffer containing 50 mM Tris-HCl (pH 7.4), 250 mM NaCl,
0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium
orthovanadate, 5 mM NaF, 10 µg of aprotinin ml
1, and 10 µg of leupeptin ml
1 (all protease inhibitors from
Sigma). Lysates were frozen, thawed, and clarified. From these
extracts, Cdk4 and Cdk6 were detected by immunoblot analysis (30 µg
of protein) or immunoprecipitated (300 µg of protein) with anti-Cdk6
and anti-Cdk4 rabbit serum (Santa Cruz Biotechnology). Immune complexes
were collected with protein A-agarose (Santa Cruz Biotechnology) and
washed four times with a lysis buffer and twice with a kinase buffer
(20 mM Tris [pH 7.4], 7.5 mM MgCl2, 1 mM dithiothreitol).
For kinase assays, the beads were resuspended in 40 µl of kinase
buffer and incubated at 37°C for 30 min in the presence of 30 µM
ATP, 5 µCi of [
-32P]ATP, and 4 µg of glutathione
S-transferase-Rb fusion protein. Products were analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by
autoradiography, and quantitated by phosphorimaging. The Rb substrate
was prepared in Escherichia coli from an expression vector
that was kindly supplied by Jae U. Jung (32). The
glutathione S-transferase fusion protein contains the
Rb-coding region from codons 379 to 928.
 |
RESULTS |
Construction of recombinant rhadinovirus for
tetracycline-repressible tax expression.
To
investigate whether HTLV genes are required not only for inducing
immortalization but also for maintaining T-cell proliferation, a
recombinant rhadinovirus with repressible tax expression was constructed. This vector efficiently infects primary T lymphocytes, and
recombinant vectors persist in T cells as episomes without expressing
rhadinoviral genes. To achieve repressible gene expression, we adapted
the tetracycline system to an application in the rhadinovirus vector.
The tax sequences were cloned under the control of the tTA
promoter, combined with the gene encoding the transcriptional activator
(tTA), and introduced into a recombination plasmid. The
plasmid was cotransfected with infectious virion DNA into permissive
tissue cultures, where homologous recombination took place. The vector
strain used is a nontransforming, apathogenic deletion variant of the
subgroup A herpesvirus saimiri. The wild-type strain from which the
vector strain is derived, like all wild-type strains of subgroup A,
does not immortalize human cells. The deletion variant has lost some
3.5-kb sequences coding for a protein (STP-A) which transforms rat
fibroblasts and induces tumors in nude mice (13, 42).
Recombinant viruses were isolated and characterized. Southern blot
analysis showed that the viruses contained the expected insert of about
10 kb (Fig. 1A). Subsequently, the
recombinant viruses were tested for repressible tax
expression. Infected permissive monkey kidney cells (OMK-637) and a
human T lymphocyte cell line (SS8tetTax), which is persistently
infected with the recombinant virus, were maintained in both the
presence and absence of tetracycline. Immunoblot analyses revealed high
levels of tax expression in the absence of tetracycline. No
detectable Tax protein was present in cells which had been exposed to
tetracycline (Fig. 1B). As expected, these differences in Tax protein
expression correlate with different amounts of tax RNA
detectable in untreated and tetracycline-treated cells (data not
shown). These data show that the tTA system is functional within
rhadinovirus vectors and that tax expression in this context
is efficiently repressible by tetracycline both in permissive and
nonpermissive cells.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 1.
Tetracycline-repressible tax expression from
a recombinant rhadinovirus. (A) Insertion of the repressible
tax expression cassette into the rhadinovirus vector. The
tax expression is controlled by a chimeric promoter
containing binding sites (tetracycline operator, TetO) for the
artificial transactivator (tTA). The genes coding for Tax, the
artificial transactivator (tTA), and the neomycin phosphotransferase
(NeoR) were inserted into the right end of the coding
sequences of the transformation-defective deletion variant S4 of
herpesvirus saimiri strain A11 (A11#S4). (B) Immunoblot analysis of
tax expression in lytically and persistently infected cells.
Permissive OMK-637 cells were infected in the presence or absence of
tetracycline (Tet) with the recombinant virus stock Hs86-S (lanes 1 and
2) or with the vector (S4) alone (lane 3). After the appearance of
distinct cytopathic changes, the cells were lysed. Proteins were also
extracted from a persistently infected T cell line (SS8tetTax) which
had been kept in the presence or absence of tetracycline (lanes 5 and
6) and from HuT102, a cell line infected with HTLV-1 (lane 4). Proteins
(20 µg/lane) were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, blotted, and reacted with anti-Tax monoclonal
antibodies.
|
|
Generation of immortalized human T lymphocytes.
To determine
the impact of Tax on T-cell proliferation, it was necessary to
introduce the repressible transactivator gene into primary human T
cells. To this end, lymphocytes from cord blood were infected with the
tax-expressing recombinant virus. As expected from earlier
work (22), permanently growing cells could be established
only from cells infected with the tax-expressing recombinants and not by infection with the vector strain. These cells
(Tesi cells) were in a permanent culture for more than 1 year and thus
were considered immortalized. In the presence of exogenous IL-2, the
cultures grew with a doubling time of about 1 week. Phenotypically,
they resemble activated T-helper lymphocytes since they express CD4,
CD25, CD3, CD45, CD69, and FAS (CD95) but no CD8. According to these
data, they are very similar to T cells immortalized with other
tax-expressing rhadinovirus recombinants or HTLV-1 (22,
56a). The cells immortalized by the repressible tax
contain persisting episomal DNA of the recombinant rhadinovirus (data
not shown). As expected from earlier experiments, the cultures did not
produce infectious recombinant viruses. This was verified by
cocultivation with permissive OMK-637 cells. Regulated tax expression was demonstrated by immunoblot analyses (Fig.
2A). In the presence of tetracycline, no
Tax expression was detectable. The Tax protein was biologically active
since it transactivated the HTLV-1 promoter (Fig. 2B). In accordance
with the expectation that Tax stimulates the IL-2R
promoter, the
repression of Tax synthesis was found to correlate strongly with
reduced IL-2R
surface expression on the immortalized T cells (Fig.
2C). These findings show that in the immortalized T cells (Tesi cells),
the tax gene is controlled efficiently by tetracycline and
that the expressed Tax protein is a functional transactivator of viral and cellular gene expression.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Suppression of Tax function by tetracycline in
immortalized human T cells. Tesi cells were cultivated in the presence
or absence of 1 µg of tetracycline (Tet) per ml. (A) Immunoblot
analysis demonstrating suppression of Tax protein expression in the
presence of tetracycline by using anti-Tax rabbit serum. Lanes: 1, HuT102 cells; 2, Jurkat cells; 3, Tesi cells; 4, Tesi cells with
tetracycline. (B) CAT assay demonstrating suppressed Tax activity in
immortalized T cells (Tesi cells). The indicated cells were transfected
with 10 µg of the reporter plasmid pU3R1-CAT containing the HTLV-1
promoter which can be stimulated by Tax. Lanes: 1, TRI-1 cells; 2, Jurkat cells; 3, Tesi cells without tetracycline; 4, Tesi cells with 1 µg of tetracycline per ml. The experiment was repeated three times
with the same result. (C) Reduced IL-2R (CD25) surface expression of
immortalized T cells in the presence of tetracycline. Immortalized T
cells were stained with anti-CD25-fluorescein isothiocyanate and
analyzed by flow cytometry.
|
|
Expression of tax is required for the replication of
immortalized human lymphocytes.
To study the influence of
tax expression on T-cell proliferation, tetracycline was
added at various concentrations to the immortalized lymphocytes. As a
parameter of cell proliferation, the DNA synthesis rate was measured.
The addition of tetracycline resulted in a strong, dose-dependent
repression of [3H]thymidine incorporation (Fig.
3A). As little as 0.01 µg of
tetracycline per ml was sufficient to significantly reduce DNA
synthesis. Concentrations of 1 µg/ml prevented DNA replication
completely. The addition of 1 µg of tetracycline per ml to the
control T cell lines TRI-1, NATI-2, and SS8tetTax, however, did not
result in significant changes of [3H]thymidine
incorporation (Fig. 3A and data not shown). TRI-1 and NATI-2 cells were
immortalized by a constitutively transcribed tax gene
transduced by the same virus vector which was used for the generation
of Tesi cells. These cells phenotypically closely resemble Tesi cells.
The effect of tetracycline on DNA synthesis correlated well with
reduced proliferation rates of tetracycline-treated Tesi cell cultures
determined by counting cell numbers (data not shown). The
tetracycline-mediated antiproliferative effect is reversible and not
toxic. Cells suppressed in replication by tetracycline (1 µg/ml) for
longer than 3 weeks start to proliferate after removal of this
antibiotic (Fig. 3B). In summary, these data indicate that the
immortalized T cells require Tax for permanent proliferation.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Tax suppression results in a stop of T-cell
replication. (A) The replication of immortalized T cells depends on
tax gene expression. Tesi cells and a control cell line
(NATI-2) were cultivated for two doubling times in the absence or
presence of tetracycline (0.01, 0.1, and 1 µg/ml). As a measure of
cell proliferation, [3H]thymidine incorporation tests
were applied. The radioactivity incorporated into cells was determined
as phosphorus-stimulated luminescence per square millimeter with a
phosphor imager. The proliferation of Tesi cells was repressed by
tetracycline in a dose-dependent manner, whereas the control cell line
with constitutive Tax expression (NATI-2) was unaffected. TRI-1 and
SS8tetTax behaved like NATI-2. (B) Reversion of growth arrest. The
medium used for Tesi cells, which had been growth arrested earlier
(t = 0), was depleted of tetracycline, and replication
was analyzed 4 days later (t = 4d).
|
|
To identify the phase at which the mitogenic Tax signal stimulates the
cell cycle, the proportions of cells in the G
1, S,
and
G
2 phases were evaluated in both the presence and absence
of Tax. Flow cytometric analyses revealed that in unsynchronized
cultures, one-fifth of the
tax-expressing cells were in the
G
2 or S phase (Fig.
4). The
cultures contained almost the same numbers
of cells in the
G
1 phase (79.5%) as the HTLV-1-transformed cell
line
HuT-102 did (83.6%). In contrast, cultures which were growth
arrested
by
tax suppression consisted almost completely of cells
in
the G
1 phase (95%). These observations indicate that the
suppression
of Tax synthesis arrests immortalized cells in the
G
1 phase of
the cell cycle. Our experiments did not hint at
a Tax effect on
apoptotis in these cultures, since the number of cells
with DNA
in amounts of less than one genome copy was not significant
(data
not shown).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
Cell cycle status in proliferating and nonproliferating
tetracycline-treated Tesi cells. tax-expressing Tesi cells
were cultured in either the presence (+) or absence ( ) of
tetracycline (1 µg/ml) for three doubling times, fixed, stained with
propidium iodide, and subjected to flow cytometry. Apoptotic and dead
cells were excluded from the analysis. The dots represent the direct
results of the measurements. The lines indicate the relative calculated
proportions of cells in the G1 (light grey), S (diagonally
hatched), and G2 (dark grey) phases of the cell cycle. The
x-axis indicates fluorescence representing the DNA content.
Arrows indicate positions of cells with 2N and 4N DNA content.
|
|
To study the kinetics of Tax induction and cell cycle progression,
tetracycline was removed from Tesi cell cultures arrested
in the cell
cycle and from SS8tetTax cells. In persistently infected
T cells
(SS8tetTax), Tax protein was first detected 12 h after
tetracycline removal and reached maximal levels 8 h later (Fig.
5A). After 1 day of culture in
tetracycline-free medium, a slight
increase in the number of Tesi cells
in the S-phase fraction was
observed; after 2 days, about one-fourth of
all cells had entered
the S phase (Fig.
5B). This observation is in
accordance with
[
3H]thymidine incorporation tests, which
demonstrate the onset of
DNA replication between 25 and 43 h after
tetracycline removal
(data not shown). Based on these observations, the
time that Tax
required to initiate the S phase is estimated to be 12 to
23 h.
These times are similar to those which normal human
lymphocytes
require to proceed from the early G
1 to the S
phase (
3). After
5 days, the proportions of cells in the
G
1, S, and G
2 phases reached
the same
steady-state level as that shown in Fig.
4. In summary,
these data led
us to conclude that the mitogenic Tax signal overcomes
a block in the
G
1 phase of the lymphocytic cell cycle, thus allowing
the
cells to enter the S phase.

View larger version (17K):
[in this window]
[in a new window]

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
S-phase induction by Tax. (A) The kinetics of Tax
induction after withdrawal of tetracycline. The tax
expression in T cells that are persistently infected with the
recombinant rhadinovirus Hs86-S (SS8tetTax) was suppressed by
tetracycline. The cells were transferred to normal growth medium. To
detect Tax after the times indicated, aliquots were subjected to
immunoblot analysis. Tax expression could be detected after 12 h
at the earliest. (B) Kinetics of S-phase induction. Tesi cells were
treated with tetracycline (1 µg/ml) until DNA synthesis and
transition into the S phase had virtually ceased (0 h). After the
withdrawal of tetracycline, aliquots were subjected to flow cytometric
cell cycle analysis after 24 and 48 h as described in the legend
to Fig. 4. The cells in the S phase are indicated by shading. A slight
increase in the number of cells in the S phase could be observed at
24 h; a strong increase could be observed after 48 h.
|
|
The activities of cyclin-dependent kinases Cdk4 and Cdk6 are
increased in the presence of Tax.
To narrow down the precise
events in the G1 phase which are influenced by the Tax
protein, we analyzed the activities of the G1-phase-specific cyclin-dependent kinases Cdk4 and Cdk6.
These kinases and their cognate cyclins are almost completely absent in
quiescent (G0-phase cells); however, they are the first to be activated after entering the cell cycle. The cellular contents of
Cdks like Cdk4 and also the levels of the cognate cyclins and the p16
inhibitor are matters of regulation (20, 39, 40, 45). To
investigate whether Tax interferes with the control of these proteins,
the levels of Cdk4, Cdk6, cyclin D isotypes, and
p16INK-4A were determined. Cyclin D1 was not
analyzed since it is not present in most T cells (3, 5). The
proteins were extracted from Tesi and SS8tetTax cells which had been
kept before in the presence and absence of tetracycline to repress or
induce, respectively, Tax synthesis. Immunoblot analyses did not reveal
major differences in the amounts of cyclins, Cdks, and the Cdk
inhibitor (Fig. 6). The expression of
G1 cyclins and Cdks in the absence of Tax indicates that
growth is arrested in the G1 phase rather than in the
G0 phase.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of cyclin-dependent kinases 4 and 6 and
regulatory cofactors in the immortalized T cells. Tesi cells, the
SS8tetTax cells, and the untransduced SS8BPT (control) cells were
treated with tetracycline as indicated in Materials and Methods. Cdk4,
Cdk6, cyclin D2, cyclin D3, and p16INK-4A were
determined by immunoblotting. None of these was modulated in the
presence of Tax.
|
|
To determine whether the kinase activities of Cdk4 and Cdk6 were
affected by Tax, the complexes were immunoprecipitated and
in vitro
kinase assays were performed with Rb protein used as
a substrate. The
Cdk activities in the immortalized cord blood
(Tesi) cells expressing
tax were compared with that in Tesi cells
with a
tetracycline-repressed
tax gene. The results of two
independent
experiments show a clear correlation between Tax expression
and
the activity of each of these kinases. In the absence of Tax,
the
activity of Cdk4 was close to the background and approximately
10-fold
stimulated if Tax expression was induced (Fig.
7A). Similarly,
the activity of Cdk6 was
enhanced in the Tax-immortalized cells.
Rb phosphorylation in vivo was
examined in the presence and absence
of Tax expression. Indeed, the
amounts of Cdk4 and Cdk6 activity
determined in vitro correlated well
with increased amounts of
the hyperphosphorylated substrate (Rb) in the
cells (Fig.
7B).
To determine whether the expression of Tax influences
the Cdk
activity in T lymphocytes, which proliferate independently of
Tax, SS8tetTax cells were analyzed. In standard culture medium
which
includes supplements of IL-2 and FCS, a minimal reduction
in Cdk6
activity was observed if
tax was suppressed. Nevertheless,
this correlated with a reduced cellular content of hyperphosphorylated
Rb protein (Fig.
7B). The Tax effect on Cdk6 was found markedly
increased in SS8tetTax cells which had been deprived of IL-2 and
FCS
for 24 h (data not shown). Under these conditions, Tax also
has a
moderate stimulatory effect on the proliferation of this
T-cell line.
These observations suggest that the Tax signal might
compensate for the
lack of FCS or IL-2 in the activation of the
Cdks. In summary, the
experiments indicate that the mitogenic
signals created by Tax result
in activation of both Cdk4 and Cdk6.
These observations are consistent
with a Tax-mediated INK-4 inactivation.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 7.
Enhanced activity of Cdk4 and Cdk6 in the presence of
Tax. Cells with induced or repressed Tax genes were lysed, and
holoenzyme complexes containing Cdk6 or Cdk4 were immunoprecipitated.
The kinase activity was assessed in vitro by using recombinant Rb
protein as a substrate. (A) Cdk4 and Cdk6 activity of the cell line
Tesi in the presence ( Tet) and absence (+Tet) of Tax. Quantification
of the kinase activity from two independent experiments is shown
graphically at the bottom of panel A. The kinase activities were
normalized to the activities in untreated Tesi cells. The T-cell line
SS8BPT was used as a tax-negative control. (B) Immunoblot
analysis of Rb protein in Tesi and SS8tetTax cells. The upper band
represents hyperphosphorylated forms (ppRb), while the lower band
represents the hypophosphorylated protein (pRb).
|
|
 |
DISCUSSION |
To understand how the HTLV-1 transactivator (Tax) protein
contributes to the growth regulation of HTLV-1-immortalized T cells, we
transduced a conditional tetracycline-repressible tax gene into primary human lymphocytes. This resulted in the immortalization of
T cells which require Tax for growth. With Tax present, the T
lymphocytes were released from a reversible G1-phase arrest and the cyclin-dependent kinases Cdk4 and Cdk6 were activated. This
demonstrates that Tax is required for stimulating the
G1-phase progression in immortalized T cells and suggests
that the mitogenic Tax effect is mediated by Cdk4 and/or Cdk6.
The repressible tax gene was transduced into primary human
lymphocytes by using a rhadinovirus vector, which is appropriate to
incorporate three different functional genes (tax,
tTA, and neomycin resistance gene) with a total size of
about 10 kb. This example shows the usefulness of our vector system for
simultaneous transfer of multiple regulated genes into human primary
cells. The integration of large stretches of foreign DNA into the
vector system is facilitated by the unique genome structure of
rhadinoviruses, which have repetitive, potentially replaceable
sequences at the ends of their genomes. The recombinant virus is also
an example of a functional tetracycline-regulated expression system
that can be completely inserted into DNA viruses. The artificial
transactivator neither influences the cell cycle (54, 55)
nor is tumorigenic in transgenic mice (19). The growth
arrest mediated by the addition of tetracycline to cells containing the
repressible tax gene is not caused by a toxic effect, since
the concentrations applied are far below the toxicity threshold
(21). Growth-arrested cells survive for more than 3 weeks in
the presence of tetracycline. It is rather improbable that genes of the
rhadinovirus contribute to the immortalized phenotype for the following
reasons. (i) The only transcription found in human T cells originates
in the genomic region, which is deleted in the vector strain used
(16). (ii) No viral transcripts were found in T cells
infected and immortalized by recombinants constitutively expressing
tax (24). (iii) No infectious virus particles are
synthesized, as previously shown with several other human lymphocyte
lines infected with herpesvirus saimiri recombinants (22,
57). This failure to synthesize virions in human lymphocytic
cells correlates with the lack of immediate-early gene expression
(16, 57). These genes are essential for the expression of
all other classes of viral mRNA in herpesviruses.
The cells immortalized by Tax grow in the presence of IL-2. The
moderate reduction of IL-2R
(CD25) expression on the surface of
growth-arrested immortalized cells, which was observed after Tax
withdrawal, cannot explain the stimulatory effect of Tax. IL-2R
is
only one component of the IL-2 receptor, and the
chain is not
directly involved in signal transduction but rather enhances the
affinity of the IL-2 receptor complex to its ligand (64). The remaining enhancing effect of the moderate numbers of
chains on
the growth-arrested Tesi cells should be sufficient to mediate the full
IL-2 signal. In addition, the large excess of IL-2 in the medium should
compensate for the IL-2R
reduction. These arguments corroborate that
Tax can stimulate T-cell growth by a mechanism which is different from
the mechanism stimulating IL-2R
expression.
In contrast to cells that express inducible Tax in the background of
established leukemia lines, the immortalized T cells described here are
unique since their growth depends on the presence of Tax and expression
of the gene encoding Tax can be controlled by tetracycline. Therefore,
these cells allow us to correlate the biochemical effects of Tax on
cellular gene expression or signalling with cellular growth. By using
this system, we found that the activities of the cyclin-dependent
kinases Cdk4 and Cdk6 were stimulated in the presence of Tax, which
correlates with cellular proliferation. The expression of the Cdks and
cyclin D isoforms was unaffected, suggesting that Tax has activated
these kinases. Tax can activate Cdk4 by binding to the Cdk inhibitor p16 in vitro (60). This mechanism may also account for the
Cdk activation in immortalized primary human T cells. The Cdks binding to D cyclins are rate limiting for the G1-phase
progression; interference with their function can cause
G1-phase arrest (8, 15, 52, 54, 56, 63). The
reduced activity of Cdk4 and Cdk6 thus may explain the growth arrest in
phase G1 in the absence of Tax. These data also suggest
that the growth-stimulating signal produced by Tax acts on Cdk4 and
Cdk6. This conclusion agrees with the observation that the Rb protein
of the immortalized Tesi cells is hyperphosphorylated in the presence
of Tax. This result is consistent with earlier observations that Rb is
continuously hyperphosphorylated in HTLV-1-infected cells
(28).
The mechanism by which Tax acts to stimulate cell cycle progression,
activation of Cdk4 and Cdk6, differs from that of other tumor virus
oncoproteins which bind directly to Rb, such as the adenovirus E1A, the
simian virus 40 T antigen, and the human papillomavirus type 16 E7. The
Rb-binding proteins have effects similar to those of cellular mutations
inactivating the Rb function: both result in down-regulation of
Cdk4-Cdk6 activity in transformed and immortalized cells (9, 36,
49). In summary, we have demonstrated for the first time that Tax
expression, T-cell growth, and Cdk4 and Cdk6 activities are linked in
immortalized primary human T cells. The data hint at a novel strategy
of viral oncogenes to overcome the cell cycle control of the Rb tumor
suppressor and to induce cell proliferation.
 |
ACKNOWLEDGMENTS |
This work was supported by the Deutsche Forschungsgemeinschaft
(SFB-466) and Wilhelm Sauder Stiftung.
We are grateful to Edgar Meinl, O. John Semmes, Bryan Cullen, Beatrice
Langton, and the AIDS Research and Reference Reagent Program (Division
of AIDS, NIAID) for kindly providing the cell line SS8BPT, antisera,
and anti-Tax hybridomas. The excellent technical assistance of Claudia
Koch is appreciated. We thank Hermann Bujard, Sabine Lang, and Andreas
Baur for helpful discussions and Bernhard Fleckenstein for his
permanent and generous support of this study.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Klinische und Molekulare Virologie der Friedrich-Alexander
Universität Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany. Phone: 49-9131-856784. Fax: 49-9131-852101. E-mail: rfgrassm{at}viro.med.uni-erlangen.de.
 |
REFERENCES |
| 1.
|
Adya, N., and C.-Z. Giam.
1995.
Distinct regions in human T-cell lymphotropic virus type I Tax mediate interactions with activator protein CREB and basal transcription factors.
J. Virol.
69:1834-1841[Abstract].
|
| 2.
|
Adya, N.,
L. J. Zhao,
W. Huang,
I. Boros, and C. Z. Giam.
1994.
Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB.
Proc. Natl. Acad. Sci. USA
91:5642-5646[Abstract/Free Full Text].
|
| 3.
|
Ajchenbaum, F.,
K. Ando,
J. A. DeCaprio, and J. D. Griffin.
1993.
Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
J. Biol. Chem.
268:4113-4119[Abstract/Free Full Text].
|
| 4.
|
Akagi, T.,
H. Ono, and K. Shimotohno.
1995.
Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1.
Blood
86:4243-4249[Abstract/Free Full Text].
|
| 5.
|
Akagi, T.,
H. Ono, and K. Shimotohno.
1996.
Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1.
Oncogene
12:1645-1652[Medline].
|
| 6.
|
Akagi, T., and K. Shimotohno.
1993.
Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.
J. Virol.
67:1211-1217[Abstract/Free Full Text].
|
| 7.
|
Alt, M.,
B. Fleckenstein, and R. Grassmann.
1991.
A pair of selectable herpesvirus vectors for simultaneous gene expression in human lymphoid cells.
Gene
102:265-269[Medline].
|
| 8.
|
Baldin, V.,
J. Lukas,
M. J. Marcote,
M. Pagano, and G. Draetta.
1993.
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
Genes Dev.
7:812-821[Abstract/Free Full Text].
|
| 9.
|
Bates, S.,
D. Parry,
L. Bonetta,
K. Vousden,
C. Dickson, and G. Peters.
1994.
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.
Oncogene
9:1633-1640[Medline].
|
| 10.
|
Brauweiler, A.,
P. Garl,
A. A. Franklin,
H. A. Giebler, and J. K. Nyborg.
1995.
A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation.
J. Biol. Chem.
270:12814-12822[Abstract/Free Full Text].
|
| 11.
|
Burton, J. D.,
R. N. Bamford,
C. Peters,
A. J. Grant,
G. Kurys,
C. K. Goldman,
J. Brennan,
E. Roessler, and T. A. Waldmann.
1994.
A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
Proc. Natl. Acad. Sci. USA
91:4935-4939[Abstract/Free Full Text].
|
| 12.
|
Cross, S. L.,
M. B. Feinberg,
J. B. Wolf,
N. J. Holbrook,
F. Wong Staal, and W. J. Leonard.
1987.
Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.
Cell
49:47-56[Medline].
|
| 13.
|
Desrosiers, R. C.,
D. P. Silva,
L. M. Waldron, and N. L. Letvin.
1986.
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization.
J. Virol.
57:701-705[Abstract/Free Full Text].
|
| 14.
|
Ewen, M. E.,
H. K. Sluss,
C. J. Sherr,
H. Matsushime,
J. Kato, and D. M. Livingston.
1993.
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
Cell
73:487-497[Medline].
|
| 15.
|
Ewen, M. E.,
H. K. Sluss,
L. L. Whitehouse, and D. M. Livingston.
1993.
TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.
Cell
74:1009-1020[Medline].
|
| 16.
|
Fickenscher, H.,
B. Biesinger,
A. Knappe,
S. Wittmann, and B. Fleckenstein.
1996.
Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes.
J. Virol.
70:6012-6019[Abstract].
|
| 17.
|
Fujii, M.,
T. Niki,
T. Mori,
T. Matsuda,
M. Matsui,
N. Nomura, and M. Seiki.
1991.
HTLV-1 Tax induces expression of various immediate early serum responsive genes.
Oncogene
6:1023-1029[Medline].
|
| 18.
|
Fujii, M.,
H. Tsuchiya,
T. Chuhjo,
T. Akizawa, and M. Seiki.
1992.
Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes.
Genes Dev.
6:2066-2076[Abstract/Free Full Text].
|
| 19.
|
Furth, P. A.,
L. St. Onge,
H. Boger,
P. Gruss,
M. Gossen,
A. Kistner,
H. Bujard, and L. Hennighausen.
1994.
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Proc. Natl. Acad. Sci. USA
91:9302-9306[Abstract/Free Full Text].
|
| 20.
|
Geng, Y., and R. A. Weinberg.
1993.
Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.
Proc. Natl. Acad. Sci. USA
90:10315-10319[Abstract/Free Full Text].
|
| 21.
|
Gossen, M., and H. Bujard.
1992.
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Proc. Natl. Acad. Sci. USA
89:5547-5551[Abstract/Free Full Text].
|
| 22.
|
Grassmann, R.,
S. Berchtold,
I. Radant,
M. Alt,
B. Fleckenstein,
J. G. Sodroski,
W. A. Haseltine, and U. Ramstedt.
1992.
Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.
J. Virol.
66:4570-4575[Abstract/Free Full Text].
|
| 23.
|
Grassmann, R.,
C. Dengler,
I. Muller Fleckenstein,
B. Fleckenstein,
K. McGuire,
M. C. Dokhelar,
J. G. Sodroski, and W. A. Haseltine.
1989.
Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a herpesvirus saimiri vector.
Proc. Natl. Acad. Sci. USA
86:3351-3355[Abstract/Free Full Text].
|
| 24.
|
Grassmann, R., and B. Fleckenstein.
1989.
Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line.
J. Virol.
63:1818-1821[Abstract/Free Full Text].
|
| 25.
|
Grassmann, R.,
B. Fleckenstein, and R. C. Desrosiers.
1994.
Viral transformation of human T-lymphocytes.
Adv. Cancer Res.
63:211-243[Medline].
|
| 26.
|
Grossman, W.,
J. T. Kimata,
F. H. Wong,
M. Zutter, and L. Ratner.
1995.
Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.
Proc. Natl. Acad. Sci. USA
92:1057-1061[Abstract/Free Full Text].
|
| 27.
|
Himes, S. R.,
L. S. Coles,
R. Katsikeros,
R. K. Lang, and M. F. Shannon.
1993.
HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF- B with other transcription factor families.
Oncogene
8:3189-3197[Medline].
|
| 28.
|
Hollsberg, P.,
L. J. Ausubel, and D. A. Hafler.
1994.
Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression.
J. Immunol.
153:566-573[Abstract].
|
| 29.
|
Inatsuki, A.,
M. Yasukawa, and Y. Kobayashi.
1989.
Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I.
J. Immunol.
143:1327-1333[Abstract].
|
| 30.
|
Inoue, J.,
M. Seiki,
T. Taniguchi,
S. Tsuru, and M. Yoshida.
1986.
Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1.
EMBO J.
5:2883-2888[Medline].
|
| 31.
|
Jeang, K. T.,
S. G. Widen,
O. J. Semmes, and S. H. Wilson.
1990.
HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene.
Science
247:1082-1084[Abstract/Free Full Text].
|
| 32.
|
Jung, J. U.,
M. Stager, and R. C. Desrosiers.
1994.
Virus-encoded cyclin.
Mol. Cell. Biol.
14:7235-7244[Abstract/Free Full Text].
|
| 33.
|
Kanno, T.,
K. Brown,
G. Franzoso, and U. Siebenlist.
1994.
Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF- B.
Mol. Cell. Biol.
14:6443-6451[Abstract/Free Full Text].
|
| 34.
|
Kato, J.,
H. Matsushime,
S. W. Hiebert,
M. E. Ewen, and C. J. Sherr.
1993.
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
Genes Dev.
7:331-342[Free Full Text].
|
| 35.
|
Khatib, Z. A.,
H. Matsushime,
M. Valentine,
D. N. Shapiro,
C. J. Sherr, and A. T. Look.
1993.
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Cancer Res.
53:5535-5541[Abstract/Free Full Text].
|
| 36.
|
Khleif, S. N.,
J. DeGregori,
C. L. Yee,
G. A. Otterson,
F. J. Kaye,
J. R. Nevins, and P. M. Howley.
1996.
Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Proc. Natl. Acad. Sci. USA
93:4350-4354[Abstract/Free Full Text].
|
| 37.
|
Kim, S. J.,
J. H. Kehrl,
J. Burton,
C. L. Tendler,
K. T. Jeang,
D. Danielpour,
C. Thevenin,
K. Y. Kim,
M. B. Sporn, and A. B. Roberts.
1990.
Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 Tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.
J. Exp. Med.
172:121-129[Abstract/Free Full Text].
|
| 38.
|
Koga, Y.,
N. Oh Hori,
H. Sato,
N. Yamamoto,
G. Kimura, and K. Nomoto.
1989.
Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
J. Immunol.
142:4493-4499[Abstract].
|
| 39.
|
Lucas, J. J.,
A. Szepesi,
J. F. Modiano,
J. Domenico, and E. W. Gelfand.
1995.
Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
J. Immunol.
154:6275-6284[Abstract].
|
| 40.
|
Matsushime, H.,
M. E. Ewen,
D. K. Strom,
J. Y. Kato,
S. K. Hanks,
M. F. Roussel, and C. J. Sherr.
1992.
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Cell
71:323-334[Medline].
|
| 41.
|
Matsushime, H.,
D. E. Quelle,
S. A. Shurtleff,
M. Shibuya,
C. J. Sherr, and J. Y. Kato.
1994.
D-type cyclin-dependent kinase activity in mammalian cells.
Mol. Cell. Biol.
14:2066-2076[Abstract/Free Full Text].
|
| 42.
|
Meinl, E.,
R. Hohlfeld,
H. Wekerle, and B. Fleckenstein.
1995.
Immortalization of human T cells by herpesvirus saimiri.
Immunol. Today
16:55-58[Medline].
|
| 43.
|
Meyerson, M., and E. Harlow.
1994.
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Mol. Cell. Biol.
14:2077-2086[Abstract/Free Full Text].
|
| 44.
|
Migone, T. S.,
J. X. Lin,
A. Cereseto,
J. C. Mulloy,
J. J. O'Shea,
G. Franchini, and W. J. Leonard.
1995.
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
Science
269:79-81[Abstract/Free Full Text].
|
| 45.
|
Modiano, J. F.,
J. Domenico,
A. Szepesi,
J. J. Lucas, and E. W. Gelfand.
1994.
Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells.
J. Biol. Chem.
269:32972-32978[Abstract/Free Full Text].
|
| 46.
|
Mori, N., and D. Prager.
1996.
Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins.
Blood
87:3410-3417[Abstract/Free Full Text].
|
| 47.
|
Nerenberg, M. I.,
S. H. Hinrichs,
R. K. Reynolds,
G. Khoury, and G. Jay.
1987.
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.
Science
237:1324-1329[Abstract/Free Full Text].
|
| 48.
|
Okamoto, A.,
D. J. Demetrick,
E. A. Spillare,
K. Hagiwara,
S. P. Hussain,
W. P. Bennett,
K. Forrester,
B. Gerwin,
M. Serrano,
D. H. Beach, et al.
1994.
Mutations and altered expression of p16INK4 in human cancer.
Proc. Natl. Acad. Sci. USA
91:11045-11049[Abstract/Free Full Text].
|
| 49.
|
Parry, D.,
S. Bates,
D. J. Mann, and G. Peters.
1995.
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.
EMBO J.
14:503-511[Medline].
|
| 50.
|
Poiesz, B. J.,
F. W. Ruscetti,
A. F. Gazdar,
P. A. Bunn,
J. D. Minna, and R. C. Gallo.
1980.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
Proc. Natl. Acad. Sci. USA
77:7415-7419[Abstract/Free Full Text].
|
| 51.
|
Pozzatti, R.,
J. Vogel, and G. Jay.
1990.
The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells.
Mol. Cell. Biol.
10:413-417[Abstract/Free Full Text].
|
| 52.
|
Quelle, D. E.,
R. A. Ashmun,
S. A. Shurtleff,
J. Y. Kato,
D. Bar Sagi,
M. F. Roussel, and C. J. Sherr.
1993.
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Genes Dev.
7:1559-1571[Abstract/Free Full Text].
|
| 53.
|
Reid, R. L.,
P. F. Lindholm,
A. Mireskandari,
J. Dittmer, and J. N. Brady.
1993.
Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I.
Oncogene
8:3029-3036[Medline].
|
| 54.
|
Resnitzky, D.,
M. Gossen,
H. Bujard, and S. I. Reed.
1994.
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.
Mol. Cell. Biol.
14:1669-1679[Abstract/Free Full Text].
|
| 55.
|
Resnitzky, D.,
L. Hengst, and S. I. Reed.
1995.
Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.
Mol. Cell. Biol.
15:4347-4352[Abstract].
|
| 56.
|
Resnitzky, D., and S. I. Reed.
1995.
Different roles for cyclins D1 and E in regulation of the G1-to-S transition.
Mol. Cell. Biol.
15:3463-3469[Abstract].
|
| 56a.
| Rosin, O. Unpublished observations.
|
| 57.
|
Simmer, B.,
M. Alt,
I. Buckreus,
S. Berthold,
B. Fleckenstein,
E. Platzer, and R. Grassmann.
1991.
Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines.
J. Gen. Virol.
72:1953-1958[Abstract/Free Full Text].
|
| 58.
|
Sun, S.-C.,
J. Elwood,
C. Béraud, and W. C. Greene.
1994.
Human T-cell leukemia virus type I Tax activation of NF- B/Rel involves phosphorylation and degradation of I B and RelA (p65)-mediated induction of the c-rel gene.
Mol. Cell. Biol.
14:7377-7384[Abstract/Free Full Text].
|
| 59.
|
Sun, S. C.,
P. A. Ganchi,
D. W. Ballard, and W. C. Greene.
1993.
NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
Science
259:1912-1915[Abstract/Free Full Text].
|
| 60.
|
Suzuki, T.,
S. Kitao,
H. Matsushime, and M. Yoshida.
1996.
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
EMBO J.
15:1607-1614[Medline].
|
| 61.
|
Suzuki, T.,
S. Kitao,
H. Matsushime, and M. Yoshida.
1996.
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
EMBO J.
15:1607-1614.
|
| 62.
|
Tanaka, A.,
C. Takahashi,
S. Yamaoka,
T. Nosaka,
M. Maki, and M. Hatanaka.
1990.
Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.
Proc. Natl. Acad. Sci. USA
87:1071-1075[Abstract/Free Full Text].
|
| 63.
|
van den Heuvel, S., and E. Harlow.
1993.
Distinct roles for cyclin-dependent kinases in cell cycle control.
Science
262:2050-2054[Abstract/Free Full Text].
|
| 64.
|
Waldmann, T. A.
1989.
The multi-subunit interleukin-2 receptor.
Annu. Rev. Biochem.
58:875-911[Medline].
|
| 65.
|
Weber, F.,
E. Meinl,
K. Drexler,
A. Czlonkowska,
S. Huber,
H. Fickenscher,
I. Muller Fleckenstein,
B. Fleckenstein,
H. Wekerle, and R. Hohlfeld.
1993.
Transformation of human T-cell clones by herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein-specific T cells.
Proc. Natl. Acad. Sci. USA
90:11049-11053[Abstract/Free Full Text].
|
| 66.
|
Yoshida, M.,
I. Miyoshi, and Y. Hinuma.
1982.
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.
Proc. Natl. Acad. Sci. USA
79:2031-2035[Abstract/Free Full Text].
|
J Virol, January 1998, p. 633-640, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kesic, M., Ward, M., Semmes, O. J., Green, P. L.
(2009). Site-Specific Phosphorylation Regulates Human T-Cell Leukemia Virus Type 2 Rex Function In Vivo. J. Virol.
83: 8859-8868
[Abstract]
[Full Text]
-
Xie, L., Kesic, M., Yamamoto, B., Li, M., Younis, I., Lairmore, M. D., Green, P. L.
(2009). Human T-Cell Leukemia Virus Type 2 Rex Carboxy Terminus Is an Inhibitory/Stability Domain That Regulates Rex Functional Activity and Viral Replication. J. Virol.
83: 5232-5243
[Abstract]
[Full Text]
-
Li, M., Kesic, M., Yin, H., Yu, L., Green, P. L.
(2009). Kinetic Analysis of Human T-Cell Leukemia Virus Type 1 Gene Expression in Cell Culture and Infected Animals. J. Virol.
83: 3788-3797
[Abstract]
[Full Text]
-
Silbermann, K., Schneider, G., Grassmann, R.
(2008). Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-{kappa}B and NFAT. J. Gen. Virol.
89: 2788-2798
[Abstract]
[Full Text]
-
Liu, M., Yang, L., Zhang, L., Liu, B., Merling, R., Xia, Z., Giam, C.-Z.
(2008). Human T-Cell Leukemia Virus Type 1 Infection Leads to Arrest in the G1 Phase of the Cell Cycle. J. Virol.
82: 8442-8455
[Abstract]
[Full Text]
-
Mihaylova, V. T., Green, A. M., Khurgel, M., Semmes, O. J., Kupfer, G. M.
(2008). Human T-Cell Leukemia Virus I Tax Protein Sensitizes p53-Mutant Cells to DNA Damage. Cancer Res.
68: 4843-4852
[Abstract]
[Full Text]
-
Pichler, K., Kattan, T., Gentzsch, J., Kress, A. K., Taylor, G. P., Bangham, C. R. M., Grassmann, R.
(2008). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. Blood
111: 4741-4751
[Abstract]
[Full Text]
-
Taylor, G P
(2007). Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J. Clin. Pathol.
60: 1392-1396
[Abstract]
[Full Text]
-
Twizere, J.-C., Springael, J.-Y., Boxus, M., Burny, A., Dequiedt, F., Dewulf, J.-F., Duchateau, J., Portetelle, D., Urbain, P., Lint, C. V., Green, P. L., Mahieux, R., Parmentier, M., Willems, L., Kettmann, R.
(2007). Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood
109: 1051-1060
[Abstract]
[Full Text]
-
Waldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B. R., Grassmann, R.
(2006). Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood
107: 4491-4499
[Abstract]
[Full Text]
-
Peloponese, J.-M. Jr., Haller, K., Miyazato, A., Jeang, K.-T.
(2005). Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl. Acad. Sci. USA
102: 18974-18979
[Abstract]
[Full Text]
-
Awasthi, S., Sharma, A., Wong, K., Zhang, J., Matlock, E. F., Rogers, L., Motloch, P., Takemoto, S., Taguchi, H., Cole, M. D., Luscher, B., Dittrich, O., Tagami, H., Nakatani, Y., McGee, M., Girard, A.-M., Gaughan, L., Robson, C. N., Monnat, R. J. Jr., Harrod, R.
(2005). A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions. Mol. Cell. Biol.
25: 6178-6198
[Abstract]
[Full Text]
-
Peloponese, J.-M. Jr., Iha, H., Yedavalli, V. R. K., Miyazato, A., Li, Y., Haller, K., Benkirane, M., Jeang, K.-T.
(2004). Ubiquitination of Human T-Cell Leukemia Virus Type 1 Tax Modulates Its Activity. J. Virol.
78: 11686-11695
[Abstract]
[Full Text]
-
Younis, I., Khair, L., Dundr, M., Lairmore, M. D., Franchini, G., Green, P. L.
(2004). Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator. J. Virol.
78: 11077-11083
[Abstract]
[Full Text]
-
Yoshizuka, N., Moriuchi, R., Mori, T., Yamada, K., Hasegawa, S., Maeda, T., Shimada, T., Yamada, Y., Kamihira, S., Tomonaga, M., Katamine, S.
(2004). An Alternative Transcript Derived from the Trio Locus Encodes a Guanosine Nucleotide Exchange Factor with Mouse Cell-transforming Potential. J. Biol. Chem.
279: 43998-44004
[Abstract]
[Full Text]
-
Sieburg, M., Tripp, A., Ma, J.-W., Feuer, G.
(2004). Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Tax Oncoproteins Modulate Cell Cycle Progression and Apoptosis. J. Virol.
78: 10399-10409
[Abstract]
[Full Text]
-
Waldele, K., Schneider, G., Ruckes, T., Grassmann, R.
(2004). Interleukin-13 Overexpression by Tax Transactivation: a Potential Autocrine Stimulus in Human T-Cell Leukemia Virus-Infected Lymphocytes. J. Virol.
78: 6081-6090
[Abstract]
[Full Text]
-
Chen, L., Ma, S., Li, B., Fink, T., Zachar, V., Takahashi, M., Cuttichia, J., Tsui, L.-C., Ebbesen, P., Liu, X.
(2003). Transcriptional activation of immediate-early gene ETR101 by human T-cell leukaemia virus type I Tax. J. Gen. Virol.
84: 3203-3214
[Abstract]
[Full Text]
-
Haoudi, A., Daniels, R. C., Wong, E., Kupfer, G., Semmes, O. J.
(2003). Human T-cell Leukemia Virus-I Tax Oncoprotein Functionally Targets a Subnuclear Complex Involved in Cellular DNA Damage-Response. J. Biol. Chem.
278: 37736-37744
[Abstract]
[Full Text]
-
Liu, B., Liang, M.-H., Kuo, Y.-l., Liao, W., Boros, I., Kleinberger, T., Blancato, J., Giam, C.-Z.
(2003). Human T-Lymphotropic Virus Type 1 Oncoprotein Tax Promotes Unscheduled Degradation of Pds1p/Securin and Clb2p/Cyclin B1 and Causes Chromosomal Instability. Mol. Cell. Biol.
23: 5269-5281
[Abstract]
[Full Text]
-
Debacq, C., Asquith, B., Kerkhofs, P., Portetelle, D., Burny, A., Kettmann, R., Willems, L.
(2002). Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA
99: 10048-10053
[Abstract]
[Full Text]
-
Haller, K., Wu, Y., Derow, E., Schmitt, I., Jeang, K.-T., Grassmann, R.
(2002). Physical Interaction of Human T-Cell Leukemia Virus Type 1 Tax with Cyclin-Dependent Kinase 4 Stimulates the Phosphorylation of Retinoblastoma Protein. Mol. Cell. Biol.
22: 3327-3338
[Abstract]
[Full Text]
-
Liang, M.-H., Geisbert, T., Yao, Y., Hinrichs, S. H., Giam, C.-Z.
(2002). Human T-Lymphotropic Virus Type 1 Oncoprotein Tax Promotes S-Phase Entry but Blocks Mitosis. J. Virol.
76: 4022-4033
[Abstract]
[Full Text]
-
Ruckes, T., Saul, D., Van Snick, J., Hermine, O., Grassmann, R.
(2001). Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood
98: 1150-1159
[Abstract]
[Full Text]
-
Mori, N., Morishita, M., Tsukazaki, T., Giam, C.-Z., Kumatori, A., Tanaka, Y., Yamamoto, N.
(2001). Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor {beta} signaling through interaction with CREB-binding protein/p300. Blood
97: 2137-2144
[Abstract]
[Full Text]
-
Portis, T., Grossman, W. J., Harding, J. C., Hess, J. L., Ratner, L.
(2001). Analysis of p53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model. J. Virol.
75: 2185-2193
[Abstract]
[Full Text]
-
Ohtani, K., Iwanaga, R., Arai, M., Huang, Y., Matsumura, Y., Nakamura, M.
(2000). Cell Type-specific E2F Activation and Cell Cycle Progression Induced by the Oncogene Product Tax of Human T-cell Leukemia Virus Type I. J. Biol. Chem.
275: 11154-11163
[Abstract]
[Full Text]
-
Corcelette, S., Masse, T., Madjar, J.-J.
(2000). Initiation of translation by non-AUG codons in human T-cell lymphotropic virus type I mRNA encoding both Rex and Tax regulatory proteins. Nucleic Acids Res
28: 1625-1634
[Abstract]
[Full Text]
-
Ross, T. M., Narayan, M., Fang, Z.-Y., Minella, A. C., Green, P. L.
(2000). Human T-Cell Leukemia Virus Type 2 Tax Mutants That Selectively Abrogate NFkappa B or CREB/ATF Activation Fail To Transform Primary Human T Cells. J. Virol.
74: 2655-2662
[Abstract]
[Full Text]
-
Anderson, M. G., Scoggin, K. E. S., Simbulan-Rosenthal, C. M., Steadman, J. A.
(2000). Identification of Poly(ADP-Ribose) Polymerase as a Transcriptional Coactivator of the Human T-Cell Leukemia Virus Type 1 Tax Protein. J. Virol.
74: 2169-2177
[Abstract]
[Full Text]
-
Santiago, F., Clark, E., Chong, S., Molina, C., Mozafari, F., Mahieux, R., Fujii, M., Azimi, N., Kashanchi, F.
(1999). Transcriptional Up-Regulation of the Cyclin D2 Gene and Acquisition of New Cyclin-Dependent Kinase Partners in Human T-Cell Leukemia Virus Type 1-Infected Cells. J. Virol.
73: 9917-9927
[Abstract]
[Full Text]
-
Robek, M. D., Ratner, L.
(1999). Immortalization of CD4+ and CD8+ T Lymphocytes by Human T-Cell Leukemia Virus Type 1 Tax Mutants Expressed in a Functional Molecular Clone. J. Virol.
73: 4856-4865
[Abstract]
[Full Text]
-
Hollsberg, P.
(1999). Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I. Microbiol. Mol. Biol. Rev.
63: 308-333
[Abstract]
[Full Text]
-
Van Den Broeke, A., Bagnis, C., Ciesiolka, M., Cleuter, Y., Gelderblom, H., Kerkhofs, P., Griebel, P., Mannoni, P., Burny, A.
(1999). In Vivo Rescue of a Silent tax-Deficient Bovine Leukemia Virus from a Tumor-Derived Ovine B-Cell Line by Recombination with a Retrovirally Transduced Wild-Type tax Gene. J. Virol.
73: 1054-1065
[Abstract]
[Full Text]
-
Iwanaga, Y., Tsukahara, T., Ohashi, T., Tanaka, Y., Arai, M., Nakamura, M., Ohtani, K., Koya, Y., Kannagi, M., Yamamoto, N., Fujii, M.
(1999). Human T-Cell Leukemia Virus Type 1 Tax Protein Abrogates Interleukin-2 Dependence in a Mouse T-Cell Line. J. Virol.
73: 1271-1277
[Abstract]
[Full Text]
-
Heger, P., Rosorius, O., Koch, C., Casari, G., Grassmann, R., Hauber, J.
(1998). Multimer Formation Is Not Essential for Nuclear Export of Human T-Cell Leukemia Virus Type 1 Rex trans-Activator Protein. J. Virol.
72: 8659-8668
[Abstract]
[Full Text]
-
Neuveut, C., Low, K. G., Maldarelli, F., Schmitt, I., Majone, F., Grassmann, R., Jeang, K.-T.
(1998). Human T-Cell Leukemia Virus Type 1 Tax and Cell Cycle Progression: Role of Cyclin D-cdk and p110Rb. Mol. Cell. Biol.
18: 3620-3632
[Abstract]
[Full Text]
-
Rosin, O., Koch, C., Schmitt, I., Semmes, O. J., Jeang, K.-T., Grassmann, R.
(1998). A Human T-cell Leukemia Virus Tax Variant Incapable of Activating NF-kappa B Retains Its Immortalizing Potential for Primary T-lymphocytes. J. Biol. Chem.
273: 6698-6703
[Abstract]
[Full Text]
-
Lemasson, I., Nyborg, J. K.
(2001). Human T-cell Leukemia Virus Type I Tax Repression of p73beta Is Mediated through Competition for the C/H1 Domain of CBP. J. Biol. Chem.
276: 15720-15727
[Abstract]
[Full Text]
-
Lemoine, F. J., Marriott, S. J.
(2001). Accelerated G1 Phase Progression Induced by the Human T Cell Leukemia Virus Type I (HTLV-I) Tax Oncoprotein. J. Biol. Chem.
276: 31851-31857
[Abstract]
[Full Text]